Status:
COMPLETED
Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data
Lead Sponsor:
Octapharma
Conditions:
Bleeding
Eligibility:
All Genders
Brief Summary
To describe the characteristics of patients treated with Fibryga®, the indications and conditions of use of Fibryga® and, for patients treated " on-demand", the short-term outcomes.
Eligibility Criteria
Inclusion
- Patient with fibrinogen deficiency (congenital or acquired)
- Having received an treatment with Fibryga® during the recollection period
- Having been informed of the potential retrospective collection of their data by a Clinical Research Associate mandated by Octapharma® when Fibryga® has been delivered and who did not refuse.
Exclusion
- N/A
Key Trial Info
Start Date :
February 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04106895
Start Date
February 21 2019
End Date
February 10 2020
Last Update
May 13 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Bordeaux Study Site
Bordeaux, France, 33404
2
Le Plessis Robinsin Study Site
Le Plessis-Robinson, France, 92350
3
Marseille Study Site
Marseille, France, 13285
4
Nantes Study Site
Nantes, France, 44093